UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Amendment No. 1
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
September 19, 2012
Date of report (Date of earliest event reported)
SOLAZYME, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-35189 | 33-1077078 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
| 225 Gateway Boulevard South San Francisco, CA 94080 |
94080 | |
| (Address of Principal Executive Offices) | (Zip Code) |
(650) 780-4777
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
As previously reported on the Form 8-K filed on September 24, 2012 for Solazyme, Inc. (the “Company”), at the 2012 Annual Meeting of Stockholders of the Company, held on September 19, 2012, stockholders of the Company considered a proposal to approve, by non-binding advisory vote, the frequency of future stockholder advisory votes to approve the Company’s named executive officer compensation. As previously reported by the Company, the frequency of once every three years received the highest number of votes cast, as well as a majority of the votes cast on the proposal.
Having considered these results, the Company’s Board of Directors adopted a policy to hold an advisory vote on the compensation of the Company’s named executive officers once every three years.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SOLAZYME, INC. | ||||||
| Date: September 20, 2013 | By: | /s/ Paul Quinlan | ||||
| Paul Quinlan | ||||||
| General Counsel | ||||||